Ultragenyx Pharmaceutical
RARE
#3251
Rank
A$5.59 B
Marketcap
$57.88
Share price
-4.26%
Change (1 day)
-19.50%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$1.98 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's total liabilities are A$1.98 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ultragenyx Pharmaceutical - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$1.99 B11.84%
2023-12-31A$1.78 B1.78%
2022-12-31A$1.75 B111.88%
2021-12-31A$0.82 B5.13%
2020-12-31A$0.78 B14.39%
2019-12-31A$0.68 B338.06%
2018-12-31A$0.15 B14.28%
2017-12-31A$0.13 B48.64%
2016-12-31A$92.46 M136.53%
2015-12-31A$39.09 M145.69%
2014-12-31A$15.91 M48.77%
2013-12-31A$10.69 M179.54%
2012-12-31A$3.82 M164%
2011-12-31A$1.44 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$2.12 B 7.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.94 B-52.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.17 B-40.98%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.24 B-87.72%๐Ÿ‡บ๐Ÿ‡ธ USA